Net profit of Procter & Gamble Health declined 43.73% to Rs 16.78 crore in the quarter ended June 2024 as against Rs 29.82 crore during the previous quarter ended June 2023. Sales declined 5.74% to Rs 283.88 crore in the quarter ended June 2024 as against Rs 301.18 crore during the previous quarter ended June 2023.
For the full year,net profit declined 12.42% to Rs 200.98 crore in the year ended June 2024 as against Rs 229.47 crore during the previous year ended June 2023. Sales declined 6.37% to Rs 1151.26 crore in the year ended June 2024 as against Rs 1229.62 crore during the previous year ended June 2023.
| Particulars | Quarter Ended | Year Ended |
| Jun. 2024 | Jun. 2023 | % Var. | Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 283.88 | 301.18 | -6 | 1151.26 | 1229.62 | -6 |
| OPM % | 17.00 | 15.05 | - | 26.58 | 26.40 | - |
| PBDT | 50.18 | 50.63 | -1 | 320.91 | 342.30 | -6 |
| PBT | 43.02 | 44.13 | -3 | 293.51 | 314.20 | -7 |
| NP | 16.78 | 29.82 | -44 | 200.98 | 229.47 | -12 |